Skip to main content
. 2023 Jun 9;13(26):17526–17535. doi: 10.1039/d3ra01953e

Inhibitory effects of compounds 4a–o against MAO-A, MAO-B, AChE and BChE.

Compound MAO-A MAO-B AChE BChE
aIC50 ± SEMb (μM)/% age inhibition
4a 33.23c 37.06c 42.32%c 20.54%c
4b 2.86 ± 1.51b 35.73c 31.34%c 23.65%c
4c 1.90 ± 0.25b 0.80 ± 0.27c 36.12%c 14.76%c
4d 1.44 ± 0.22b 1.04 ± 0.22c 0.83 ± 0.007a 23.67%c
4e 1.47 ± 0.45b 1.91 ± 0.89 1.96 ± 0.176a 10.54%c
4f 34.82c 39.46c 2.03 ± 0.434a 22.61%c
4g 1.21 ± 0.04b 2.02 ± 1.26 1.11 ± 0.080a 15.23%c
4h 21.87c 29.36c 1.51 ± 0.462a 12.43%c
4i 38.11c 32.53c 37.12%c 21.45%c
4j 1.02 ± 0.09b 18.57c 1.56 ± 0.309a 20.55%c
4k 3.46 ± 2.58b 1.10 ± 1.16 39.65%c 14.67%c
4l 36.81c 24.86c 44.56%c 26.91%c
4m 0.11 ± 0.001b 3.08 ± 0.06c 2.67 ± 0.029a 15.78%c
4n 21.07c 18.47c 1.23 ± 0.969a 28.87%c
4o 29.98c 22.65c 2.32 ± 0.080a 32.98%c
Clorgylined 0.005 ± 0.03 61.35 ± 1.13
Deprenyld 67.25 ± 1.02 0.019 ± 0.01
Donepezild 0.032 ± 0.003a 6.41 ± 0.34a
a

IC50 half-maximal half inhibitory concentration in micromolar range.

b

SEM standard error mean.

c

%age inhibition.

d

Positive control.